文献速递牙体牙髓病

根管内二甲双胍通过抑制iNOS表达与单核细胞募集促进根尖周炎愈合

Intracanal Metformin Promotes Healing of Apical Periodontitis via Suppressing Inducible Nitric Oxide Synthase Expression and Monocyte Recruitment.
PubMed 文献 · J Endod · 2019-11-18

本研究在LPS诱导的人单核细胞系Mono-Mac-6中评估二甲双胍对iNOS表达和NO产生的影响,并在大鼠实验性根尖周炎中比较根管清创联合或不联合根管内二甲双胍用药的疗效。结果显示二甲双胍抑制单核细胞iNOS/NO通路及CCL-2合成,根管内用药减少骨吸收、抑制iNOS表达和单核细胞募集,证实其治疗根尖周炎的有效性。

要点

  • 二甲双胍抑制LPS诱导的单核细胞iNOS表达和NO产生。
  • 二甲双胍通过iNOS/NO通路抑制LPS增强的CCL-2合成。
  • 根管内二甲双胍减少根尖周炎骨吸收及单核细胞募集。

核心结论

  • 根管内二甲双胍对根尖周炎具有治疗有效性。
  • 抑制单核细胞募集(通过调节iNOS表达和NO产生)是二甲双胍有益作用的重要机制。

研究设计与样本

  • 体外使用LPS诱导的人单核细胞系Mono-Mac-6评估iNOS表达、NO产生和CCL-2合成。
  • 体内建立大鼠实验性根尖周炎模型,行根管清创联合或不联合根管内二甲双胍用药。
  • 通过常规X线摄影和micro-CT评估病变进展,免疫组化评估iNOS表达和单核/巨噬细胞数量。

主要发现

  • 二甲双胍抑制单核细胞LPS诱导的iNOS和NO产生。
  • 二甲双胍通过调节iNOS/NO通路抑制LPS增强的CCL-2合成。
  • 根管内二甲双胍减少根尖周炎相关骨吸收。
  • 根管内二甲双胍抑制iNOS表达和单核细胞募集。

临床怎么用

  • 根管内二甲双胍用药可能作为根尖周炎的辅助治疗策略。
  • 其作用机制涉及抑制单核细胞募集和iNOS/NO通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We have previously shown that intracanal metformin ameliorates apical periodontitis, partially by modulation of osteoblast apoptosis. The action of metformin on other cell types pertinent to the development of apical periodontitis needs to be examined. In the present study, we aimed to analyze whether its effects on the expression of inducible nitric oxide synthase (iNOS) and monocyte recruitment contribute to the therapeutic effect on apical periodontitis. METHODS: Lipopolysaccharide (LPS)-induced expression of iNOS in a human monocytic cell line, Mono-Mac-6, was assessed by Western blot. The amount of nitrite in culture medium was assessed to quantify nitric oxide (NO) production. C-C motif chemokine ligand-2 (CCL-2) synthesis was measured by enzyme-linked immunosorbent assay. Experimental apical periodontitis in rats was treated with root canal debridement with or without intracanal metformin medication. Lesion progression was assessed by conventional radiography and micro-computed tomographic imaging. Cellular expression of iNOS and the number of monocytes/macrophages were assessed by immunohistochemistry. RESULTS: Metformin suppressed LPS-induced iNOS and NO production by monocytes. More importantly, metformin inhibited LPS-enhanced CCL-2 synthesis through modulation of the iNOS/NO pathway. Intracanal metformin reduced bone resorption associated with apical periodontitis and suppressed iNOS expression and monocyte recruitment. CONCLUSIONS: Our results confirmed the therapeutic efficacy of intracanal metformin for apical periodontitis. Suppression of monocyte recruitment through modulation of iNOS expression and NO production is an important mechanism underlying the beneficial effect of metformin.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Wang HW, Lai EH, Yang CN, et al. Intracanal Metformin Promotes Healing of Apical Periodontitis via Suppressing Inducible Nitric Oxide Synthase Expression and Monocyte Recruitment. J Endod. 2019. PMID: 31753516. doi:10.1016/j.joen.2019.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。